950 TOWER LANE, SUITE 1050, FOSTER CITY, CA
Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update
Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
Investor Presentation
Other Events
Announces Additional Private Placement Financing with TCGx
Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease, Investor Presentation
Reports Third Quarter 2025 Financial Results and Provides Business Update
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership